For Vascular Surgeons
Vascular surgery is the only specialty where your audience is two different people: the patient with leg symptoms searching for help, and the PCP, cardiologist, or wound-care nurse looking for someone to send them to. Generic medical marketing speaks to neither well. We build acquisition systems that work both channels — direct-to-patient demand and referrer enablement — across your full procedure mix from PAD to varicose vein to embolization.
The vascular surgery market
Vascular surgery practices serve more conditions than almost any vascular specialty. Each one has its own search behavior, referrer dynamic, and patient decision cycle.
10M+
U.S. adults with PAD
PAD is the highest-volume vascular condition you treat — and the most under-diagnosed. Most candidate patients aren't being routed by their PCPs.
>70%
Of PCPs unaware of PAD in their patients
Direct-to-patient acquisition isn't optional in vascular — it's the only way to reach patients your referring physicians aren't recognizing.
+8.1%
OBL annual growth rate
Office-based delivery is the fastest-growing setting in vascular care. The shift from hospital outpatient to OBL is reshaping competitive dynamics in every metro.
39%
Of PCP vascular referrals driven by patient request
JVS 2009: patient requests were the deciding factor in 39% of PCP referrals across vascular care. Even when patients arrive via referral, they're often the ones who pointed the referrer toward you in the first place — making direct-to-patient marketing structurally important.
Vascular surgery has a marketing problem most agencies don't even see: you're competing for the same patients across multiple specialties, with multiple audiences, across multiple procedure lines. Generic plays don't work.
Dual audience
Patients want to know if PAE/atherectomy/ablation will fix their symptoms. PCPs and cardiologists want to know who handles complex cases well. Same practice, two messaging strategies, almost zero overlap.
Procedure scope
Your service line could include PAD interventions, varicose vein, AAA repair, carotid stenting, and embolization. Each has its own buyer, its own search behavior, and its own competitive set. They can't share one ad campaign.
Authority signals
IR, IC, and vein clinics all bid against you. They lead with 'minimally invasive.' You need to communicate why surgical training and full-procedure scope matters — without sounding defensive.
Hospital context
Hospital-employed surgeons have brand support but limited marketing autonomy. Independent practices have flexibility but compete with hospital-system reach. We tune approach to your specific setting.
Your first 90 days
Vascular engagements have to balance procedure mix, referrer development, and direct-to-patient acquisition. Here's the typical sequence.
Week 1
We map your full procedure menu, current referral sources, and DTC pipeline (or lack of it). We benchmark you against local IR, IC, and vein-clinic competition. You leave with a 90-day plan that prioritizes the highest-margin, lowest-effort wins.
Weeks 2–4
We launch DTC campaigns for your top procedure lines (typically PAD + varicose vein) plus a referrer-enablement track — concise, evidence-led content for local PCPs, cardiologists, and wound care. By week 4 both channels are running.
Days 30–60
Patient intake goes live with separate paths per procedure line. PAD inquiries with severity flags get fast-tracked. Vein patients route into the dual cosmetic/medical funnel. Each procedure line gets its own scheduling logic.
Days 60–90
Your team sees consults from the system. We watch what's converting per procedure and double down. Weekly reports show qualified consults and procedures by service line — so you know which marketing dollars are funding which growth.
Why we're different
Most agencies treat vascular surgery like any other specialty. We're built for the multi-procedure, dual-audience reality.
Most agencies
Generic 'vascular practice marketing' that treats your full procedure mix as one campaign.
PatientFlow approach
Procedure-specific funnels that respect the very different patient profiles and search behaviors across PAD, vein, AAA, and embolization.
Most agencies
Ignored. Direct-to-patient only.
PatientFlow approach
Parallel referrer-enablement track — evidence-led content for local PCPs, cardiologists, and wound care so they know what to do with their hardest vascular patients.
Most agencies
Volume-focused: every form fill counts. Your team filters severity and procedure-fit manually.
PatientFlow approach
We screen by procedure, severity, and referral source before patients reach your team. Urgent PAD cases jump the queue. Cosmetic vein patients route to the right path.
Most agencies
Hands off after the lead is delivered. Long-decision elective patients quietly drop out.
PatientFlow approach
Multi-month follow-up tuned per procedure. Vein patients shop for weeks; PAD patients defer until symptoms worsen. We stay with both.
Most agencies
Reports on clicks, impressions, and form fills. ROI is left for you to calculate.
PatientFlow approach
Reports tied to scheduled procedures by service line: qualified consults, conversion, cost per scheduled procedure, revenue — broken down by procedure category.
Most agencies
Each procedure line is a separate engagement.
PatientFlow approach
Cross-procedure intake catches the patient who came in for varicose veins but actually has claudication. We capture revenue across your service lines, not just the one they searched for.
If you're a vascular surgery practice looking to grow procedure volume across PAD, vein, and beyond — or to defend share against new IR and IC entrants in your market — let's talk through what the next 90 days could look like.